Market participants were in full risk-on mode Wednesday as an AI-fueled rally in big tech stocks and a batch of upbeat corporate earnings sent stocks to fresh highs. Tech stocks dominated the list of biggest gainers after President Trump unveiled The Stargate Project,
Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of
In a report released yesterday, Robert Ottenstein from Evercore ISI maintained a Buy rating on Procter & Gamble (PG – Research Report),
Procter & Gamble beat Wall Street's estimates for its quarterly earnings and revenue. The company's volume rose 1% in its fiscal second quarter as demand for household staples like toilet paper and cleaning products rose.
Project Stargate will see companies like Oracle, SoftBank, MGX, and OpenAI commit an initial $100 billion to build data centers in the U.S.
Procter & Gamble (NYSE:PG), a global leader in consumer goods, continues to navigate a complex market environment characterized by shifting consumer behaviors, currency headwinds, and competitive pressures.
Consumers say they were misled by environmental claims Lawsuit claims company harms important Canadian forest Procter & Gamble has pledged more disclosures Jan 17 (Reuters) - A new lawsuit accuses ...
Procter & Gamble PG posted a 3% rise in organic sales on a 2% bump in volumes and a 1% benefit from favorable mix. However, margins contracted, with the firm’s adjusted gross margin down 30 basis points to 52.4% and its adjusted operating margin off 80 basis points to 26.2%.
Oracle stock is higher Wednesday after President Trump announced the $500 billion AI-focused Stargate Project. Here's what you need to know.
Good morning, and welcome to Procter & Gamble's Quarter End Conference Call. Today's event is being recorded for replay. This discussion will include a number of forward-looking statements. If you will refer to PNG's most recent 10-K,
Procter & Gamble Hygiene & Healthcare Ltd. key Products/Revenue Segments include Hygiene Products, Creams & Ointments, Cough Drops, Tablets for the year ending 30-Jun-2024.For the quarter ended 30-09-2024, the company has reported a Standalone Total Income ...